TAK Biopharma IVS — Credit Rating and Financial Key Figures

CVR number: 37962872
Ole Maaløes Vej 3, 2200 København N
todd@takbiopharma.com
tel: 25218064
www.takbiopharma.com

Income statement (kDKK)

2016
2017
2018
2019
Fiscal period length12121212
Net sales80.32205.53379.95
Costs of manufacturing-16.89-3.54-36.28-72.82
Gross profit-16.8966.53149.23299.99
Costs of management-29.95-20.02-7.14
Employee benefit expenses- 141.57
EBIT- 158.46-23.30149.23-21.93
Other financial expenses-0.05-0.01-0.26
Pre-tax profit- 158.46-23.34149.22-22.19
Net earnings- 158.46-23.34149.22-22.19

Assets (kDKK)

2016
2017
2018
2019
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables4.192.812.90
Short term receivables total4.192.812.90
Cash and bank deposits24.240.8713.5867.41
Cash and cash equivalents24.240.8713.5867.41
Balance sheet total (assets)24.245.0616.4070.31

Equity and liabilities (kDKK)

2016
2017
2018
2019
Share capital1.001.001.001.00
Retained earnings- 164.41- 187.75-38.53
Profit of the financial year- 158.46-23.34149.22-22.19
Shareholders equity total- 157.46- 186.75-37.53-59.72
Capital loans130.13144.23
Non-current liabilities total130.13144.23
Current trade creditors16.890.384.3642.88
Current owed to participating38.1340.5040.99
Other non-interest bearing current liabilities34.689.079.0746.15
Current liabilities total51.5747.5853.93130.03
Balance sheet total (liabilities)24.245.0616.4070.31
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.